Be part of the 3rd Annual Biologics Digitalisation & AI World 2026, the leading platform in Asia spotlighting the transformative power of AI and digitalisation in biologics development and manufacturing.
Accelerate innovation.
Enhance outcomes.
Experience the future of biologics – powered by AI.
KEY THEMES & TOPICS
Breaking Barriers: AI’s Expanding Role in Biopharma Discovery
Explore how artificial intelligence is accelerating target identification, drug discovery, and the path from concept to clinic.
Orchestrating Digital Ops
Discover how AI driven control towers enhance oversight, streamline operations, and improve decision making across biopharma enterprises.
Data to Discovery
See how data integration and AI powered models are reshaping drug design, biomarker discovery, and precision validation strategies.
Smart Supply Chain 4.0
Uncover how predictive analytics and AI ensure resilient, transparent, and efficient supply chains for biologics.
Digital Bioprocessing
Learn how automation and AI are optimising process development and manufacturing for advanced biologics.
From Data Integrity to Digital Compliance
Understand how AI tools can strengthen compliance, manage risks, and align with evolving global regulatory frameworks.
The Intelligent Lab
Explore next generation labs where AI, robotics, and digital twins accelerate research and enable smarter experimentation.
Ethical Intelligence
Gain insights into establishing governance frameworks, securing digital ecosystems, and ensuring ethical AI adoption in biopharma.
WHO
Biologics Digitalisation & AI World convenes decision makers, C suite executives, and senior leaders from across the global and APAC biopharma ecosystem. This includes drug discovery scientists, clinical trial professionals, manufacturing and bioprocessing specialists, supply chain executives, digitalisation leaders, and AI innovators. It is the key platform for industry pioneers, governments, and technology providers who are advancing biologics through digital transformation.
WHAT
This conference explores how digitalisation and AI are revolutionizing the biologics value chain from end to end. With a programme spanning drug discovery, development, manufacturing, clinical trials, and supply chain, the event features cutting edge case studies, interactive sessions, and solution focused discussions. Attendees will gain practical insights into how to harness AI and digitalisation for improved R&D, smarter trials, automated manufacturing, streamlined compliance, and data driven supply chain resilience.
WHY
With the global biopharma market rapidly scaling and the APAC region investing heavily in digital adoption, the future of biologics depends on intelligent integration of digitalisation and AI. These technologies are driving faster drug discovery, more efficient trials, cost effective manufacturing, and stronger supply chain reliability. Biologics Digitalisation & AI World is where leaders gather to connect, exchange ideas, and secure the knowledge and partnerships needed to stay ahead in the digital first era of biologics.
Be part of the movement shaping Asia’s digital biopharma future. Collaborate with peers, explore cutting-edge strategies, and stay ahead in an industry where intelligence is the new infrastructure
300+ Attendees
Senior professionals, decision makers, and C suite executives from across drug discovery, clinical trials, manufacturing, supply chain, digitalisation, and AI innovation in biopharma.
20+ Speakers
Industry leaders, digital pioneers, and scientific experts sharing cutting edge insights on AI adoption, digitalisation strategies, and the transformation of biologics end to end.
120+ Organisations
Representing global and APAC biopharma firms, technology providers, AI solution developers, regulatory bodies, contract manufacturers, and research institutions shaping the future of biologics.
8+ Case Studies
Real world examples of AI and digitalisation in action, from discovery to development, manufacturing, compliance, and supply chain resilience.
48+ Networking Hours
Dedicated time to connect with peers, partners, and prospects through interactive discussions, one to one meetings, roundtables, and social sessions designed to spark collaboration.
Singapore
Dedicated time to connect with peers, partners, and prospects through interactive discussions, one to one meetings, roundtables, and social sessions designed to spark collaboration.
CONTACT
